...
首页> 外文期刊>Acta biomaterialia >A liposome/gelatin methacrylate nanocomposite hydrogel system for delivery of stromal cell-derived factor-1 alpha and stimulation of cell migration
【24h】

A liposome/gelatin methacrylate nanocomposite hydrogel system for delivery of stromal cell-derived factor-1 alpha and stimulation of cell migration

机译:一种脂质体/明胶甲基丙烯酸酯纳米复合水凝胶系统,用于递送基质细胞衍生因子-1α和刺激细胞迁移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic, non-healing skin and soft tissue wounds are susceptible to infection, difficult to treat clinically, and can severely reduce a patient's quality of life. A key aspect of this issue is the impaired recruitment of mesenchymal stem cells (MSCs), which secrete regenerative cytokines and modulate the phenotypes of other effector cells that promote healing. We have engineered a therapeutic delivery system that can controllably release the pro-healing chemokine stromal cell derived factor-1 alpha (SDF-1 alpha) to induce the migration of MSCs. In order to protect the protein cargo from hydrolytic degradation and control its release, we have loaded SDF-1 alpha in anionic liposomes (lipoSDF) and embedded them in gelatin methacrylate (GelMA) to form a nanocomposite hydrogel. In this study, we quantify the release of SDF-1 alpha from our hydrogel system and measure the induced migration of MSCs in vitro via a transwell assay. Lastly, we evaluate the ability of this system to activate intracellular signaling in MSCs by using Western blots to probe for the phosphorylation of key proteins in the mTOR pathway. To our knowledge, this is the first study to report the delivery of liposomal SDF-1 alpha using a nanocomposite approach. The results of this study expand on our current understanding of factors that can be modified to affect MSC behavior and phenotype. Furthermore, our findings contribute to the development of new hydrogel-based therapeutic delivery strategies for clinical wound healing applications.
机译:慢性,非愈合皮肤和软组织伤口易感染,难治疗的临床,并且会严重降低生活的患者的生存质量。这个问题的一个关键方面是间充质干细胞(MSC),其分泌再生细胞因子和调节其它效应细胞的促进愈合的表型的受损募集。我们设计的治疗递送系统,其能够可控地释放的促愈合的趋化因子基质细胞衍生因子1α(SDF-1α),以诱导MSC的迁移。为了保护从水解降解的蛋白质货物并控制其释放,我们有加载SDF-1α在阴离子脂质体(lipoSDF)和明胶甲基丙烯酸酯(GelMA)嵌入它们形成纳米复合材料的水凝胶。在这项研究中,我们从我们的水凝胶系统量化SDF-1α的释放和测量体外通过transwell小室测定法MSCs的诱导的迁移。最后,我们评估该系统的使用免疫印迹探测关键蛋白的mTOR通路的磷酸化激活间充质干细胞内信号的能力。据我们所知,这是第一次研究使用的纳米复合材料的方法来报告脂质体SDF-1α的交付。这项研究的结果对我们目前的可进行修改以影响MSC行为和表型因素的理解扩大。此外,我们的研究结果有助于新的基于水凝胶治疗交付战略的发展临床伤口愈合的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号